FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

 

 

November 8, 2012 

MEETING ROSTER 

 

 

DESIGNATED FEDERAL OFFICER (Non-Voting)  
 
Paul T. Tran, RPh  
Division of Advisory Committee and Consultant Management  
Office of Executive Programs, CDER, FDA 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting) 
                                                                                                  
Erica H. Brittain, PhD 
Mathematical Statistician  
Biostatistics Research Branch 
National Institute of Allergy and Infectious  
Diseases (NIAID) 
National Institutes of Health (NIH) 
Bethesda, Maryland 
 

Ellen W. Seely, MD (via telephone) 
Professor of Medicine 
Harvard Medical School 
Director of Clinical Research 
Endocrinology, Diabetes and Hypertension Division 
Vice Chair for Faculty Development 
Department of Medicine 
Brigham & Women's Hospital 
Boston, Massachusetts 
 
Robert J. Smith, MD 
Professor of Medicine (Endocrinology) 
Alpert Medical School of Brown University 
East Providence, Rhode Island 
 

Ed J. Hendricks, MD 
Medical Director  
Center for Weight Management  
Roseville and Sacramento, California  

 

ACTING INDUSTRY REPRESENTATIVE TO THE COMMITTEE (Non-Voting) 
 
Rob Scott, MD 
(Acting Industry Representative) 
Vice President Global Development  
Cardiovascular Therapeutic Area Head 
One Amgen Center Drive 
Thousand Oaks, California 
 
TEMPORARY MEMBERS (Voting) 
 
Kenneth D. Burman, MD 
(Acting Chairperson)  
Chief, Endocrine Section 
Washington Hospital Center 
Washington, District of Columbia 
 

David W. Cooke, MD 
Associate Professor of Pediatrics 
Division of Pediatric Endocrinology 
Director, Pediatric Endocrine Fellowship Training 
Program  
Johns Hopkins University School of Medicine 
Baltimore, Maryland 
 
 

Page 1 of 2 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

 

 

November 8, 2012 

MEETING ROSTER (cont.) 

 

 
 
TEMPORARY MEMBERS (Voting) 
Brendan M. Everett, MD, MPH 
Associate Physician, Brigham & Women's Hospital & 
Instructor in Medicine  
Harvard Medical School 
Brigham & Women's Hospital Preventive Medicine 
Boston, Massachusetts  
 

William R. Hiatt, MD, FACP 
Professor of Medicine  
Division of Cardiology 
University of Colorado School of Medicine  
President, Colorado Prevention Center  (CPC) Clinical 
Research 
Aurora, Colorado 
 

Rebecca W. Killion  
(Patient Representative) 
Washington, District of Columbia 
 

FDA PARTICIPANTS (Non-Voting) 
 
Curtis J. Rosebraugh, MD, MPH 
Director 
Office of Drug Evaluation II (ODE-II)  
Office of New Drugs (OND), CDER, FDA  

Jean-Marc Guettier, MDCM 
Clinical Team Leader 
DMEP, ODE-II, OND, CDER, FDA 
 

 

Marvin A. Konstam, MD 
Chief Physician Executive  
The CardioVascular Center 
Tufts Medical Center 
Professor of Medicine 
Tufts University School of Medicine 
Boston, Massachusetts 
 
Charles A. Stanley, MD 
Professor of Pediatrics 
University of Pennsylvania Perelman School of 
Medicine 
Division of Endocrinology 
Childrenâ€™s Hospital of Philadelphia 
Abramson Research Center 
Philadelphia, Pennsylvania 
 
Thomas J. Weber, MD 
Training Program Director, Endocrinology, Diabetes 
and Metabolism 
Division of Endocrinology, Metabolism and Nutrition 
Duke University Medical Center 
Durham, North Carolina 
 
  
 
Mary H. Parks, MD 
Director  
Division of Metabolism and Endocrinology  
Products (DMEP) 
ODE-II, OND, CDER, FDA 
 
Mat Soukop, PhD 
Team Leader 
Division of Biometrics 7 
Office of Biostatistics (OB) 
Office of Translational Sciences (OTS), CDER, FDA 
 

Page 2 of 2 

